ATE169217T1 - Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten - Google Patents

Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten

Info

Publication number
ATE169217T1
ATE169217T1 AT92810726T AT92810726T ATE169217T1 AT E169217 T1 ATE169217 T1 AT E169217T1 AT 92810726 T AT92810726 T AT 92810726T AT 92810726 T AT92810726 T AT 92810726T AT E169217 T1 ATE169217 T1 AT E169217T1
Authority
AT
Austria
Prior art keywords
autoimmune diseases
prevent
hydrogen
alkyl group
treat autoimmune
Prior art date
Application number
AT92810726T
Other languages
English (en)
Inventor
Mitsuru Naiki
Yuichi Takeoka
Seishi Suehiro
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE169217T1 publication Critical patent/ATE169217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92810726T 1991-09-26 1992-09-23 Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten ATE169217T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27654391 1991-09-26

Publications (1)

Publication Number Publication Date
ATE169217T1 true ATE169217T1 (de) 1998-08-15

Family

ID=17570946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92810726T ATE169217T1 (de) 1991-09-26 1992-09-23 Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten

Country Status (4)

Country Link
US (2) US5376682A (de)
EP (1) EP0534907B1 (de)
AT (1) ATE169217T1 (de)
DE (1) DE69226487T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW354294B (en) * 1993-09-17 1999-03-11 Upjohn Co Substituted tetronic acids useful for treating HIV and other retroviruses
AU5417696A (en) * 1995-03-20 1996-10-08 Upjohn Company, The Substituted tetronic acids useful for treating hiv and other retroviruses
NZ335864A (en) 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US8188145B2 (en) 2002-06-12 2012-05-29 Magnachem International Laboratories, Inc. Synthetic lactone formulations and method of use
MXPA05004794A (es) 2002-11-05 2005-08-19 Magnachem Int Lab Inc Formulaciones de lactonas y metodos de uso.
US20040119052A1 (en) * 2002-12-20 2004-06-24 Beavers William Anthony Process for preparing alpha- and beta- methyl-gamma-butyrolactone and 3-methyltetrahydrofuran
US8951992B2 (en) * 2008-07-18 2015-02-10 Cornell University Mycobacterium membrane protease as a target for inhibitors of intrabacterial pH homeostasis
KR20110128785A (ko) 2008-10-24 2011-11-30 매그나켐 인터내셔널 레버러토리즈 아이엔씨 Ｒａｄ9와 선택적으로 상호작용하는 화합물들의 스크리닝방법
WO2011153502A2 (en) * 2010-06-04 2011-12-08 The Regents Of The University Of California Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3232882A1 (de) * 1982-09-02 1984-03-08 Josef Dipl.-Chem. Dr.Rer.Nat. Klosa Neues analgetikum
US5045564A (en) * 1988-12-07 1991-09-03 Allergan, Inc. Anti-inflammatory 2-furanones

Also Published As

Publication number Publication date
EP0534907B1 (de) 1998-08-05
DE69226487T2 (de) 1999-02-18
DE69226487D1 (de) 1998-09-10
EP0534907A1 (de) 1993-03-31
US5376682A (en) 1994-12-27
US5532271A (en) 1996-07-02

Similar Documents

Publication Publication Date Title
DE69430816D1 (de) Verwendung von Piperidin-Derivaten in der Behandlung von Schizophrenie
NO981528D0 (no) Substituerte imidazoler med antikreft- og cytokininhibitoraktivitet
ES2102154T3 (es) Inhibicion de trombina.
NO843836L (no) Terapeutisk aktive sulfamatderivater
GB9202791D0 (en) Compounds
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
ATE169217T1 (de) Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
NO943874D0 (no) Behandling av resistant neoplasma
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE99934T1 (de) Heteroaryl-3-oxo-propannitril-derivate, nuetzlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten.
DE69427807D1 (de) Hemmung von Hirsutismus und Alopecia bei Frauen
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE254919T1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE3889532D1 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie.
DE3770481D1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
ZA885358B (en) Uricosuric composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties